Lower levels of vWF are associated with lower risk of cardiovascular disease.

Pauline C S van ParidonMarina Panova-NoevaRene van OerleAndreas SchulzJürgen H ProchaskaNatalie ArnoldIrene SchmidtmannManfred BeutelNorbert PfeifferThomas MünzelKarl J Lackner Hugo Ten CatePhilipp S WildHenri M H Spronk

Published in: Research and practice in thrombosis and haemostasis (2022)

The study demonstrated that having low vWF activity levels were associated with a lower risk for CVD. Additionally, it revealed a decreased risk of cardiovascular and all-cause mortality in individuals with low levels of vWF antigen, shining new light on vWF as a potential target for novel therapies.

Keyphrases

cardiovascular disease
type diabetes
metabolic syndrome
climate change
cardiovascular events